| Stage | CRK | % of rev | ACA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $353M | 100.00% | $659M | 100.00% | ACA ×1.86 |
| Gross profit | $310M | 87.73% | $156M | 23.64% | CRK +64.1pp |
| Operating income | $23M | 6.39% | $84M | 12.80% | ACA +6.4pp |
| Pre-tax income | $12M | 3.44% | $62M | 9.46% | ACA +6.0pp |
| Net income | $15M | 4.25% | $329M | 49.87% | ACA +45.6pp |
| Stage | CRK | ACA | Gap · A − B |
|---|---|---|---|
| Revenue | $353M100.00% | $659M100.00% | ACA ×1.86 |
| Gross profit | 87.73%$310M | 23.64%$156M | CRK +64.1pp |
| Operating income | 6.39%$23M | 12.80%$84M | ACA +6.4pp |
| Pre-tax income | 3.44%$12M | 9.46%$62M | ACA +6.0pp |
| Net income |
| 4.25%$15M |
| 49.87%$329M |
| ACA +45.6pp |
No shared counterparties.